What is PLUR's health score?

Pluri Inc. (PLUR) has a TradeApes health score of 42 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PLUR's estimated fair value?

Based on our 5-year discounted cash flow model, Pluri Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is PLUR undervalued or overvalued?

Our model currently rates PLUR as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for PLUR... Refresh in a moment for the full analysis.

Pluri Inc. (PLUR)

Healthcare Inconclusive inconclusive weak

$2.38

Updated: 2026-06-05

TradeApes Score

Financial Strength

35 Weak

Operating Trend

50 Mixed

Relative Value

50 Mixed

Capital Allocation

10 Stressed

Risk

65 Healthy

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.